Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights

Area of Science:

• Neuroimmunology
• Neurology
• Basic Science

Background:

• Epilepsy affects 50 million globally, with unknown causes in 30% and drug resistance in another 30%.
• Intractable epilepsy leads to frequent seizures, cognitive, behavioral, and psychiatric issues.
• Autoimmune Epilepsy presents a significant challenge due to its complex etiology and treatment resistance.

Purpose of the Study:

• To provide a multidisciplinary perspective on Autoimmune Epilepsy, integrating immunological, neurological, and basic science insights.
• To summarize current knowledge and present novel discoveries regarding autoimmune antibodies in epilepsy.
• To discuss the pathogenic mechanisms, clinical implications, and therapeutic strategies for Autoimmune Epilepsy.

Main Methods:

• Review and synthesis of existing literature on autoimmune epilepsy.
• Analysis of characteristic features of autoantigens and pathological activity of associated antibodies.
• Discussion of *in vitro* and animal model data for various autoantibodies.

Main Results:

• Identified key autoantibodies targeting Glutamate receptors (AMPA-GluR3, NMDA-NR1, NMDA-NR2), GAD-65, GABA-R, GLY-R, VGKC, LGI1, CASPR2, and β2 GP1.
• AMPA-GluR3 peptide antibodies identified as highly pathogenic, inducing neural cell death via excitotoxicity, reactive oxygen species, and complement fixation.
• Autoimmunity can precede seizures, contribute to neuropathology by disrupting excitatory/inhibitory balance, and is linked to cognitive and psychiatric impairments.

Conclusions:

• Autoimmune Epilepsy is driven by specific autoantibodies that damage neural cells and disrupt brain function.
• The extracellular and synaptic nature of autoantigens facilitates antibody-mediated damage.
• Further research into therapeutic strategies is crucial for managing this complex neurological condition.